A hypercoagulable state associated with coronavirus disease 2019 (COVID-19) has been
well documented and is believed to be strongly supported by a proinflammatory state. The …

Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …

We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …

Background SARS-CoV-2 infection has noted derangements in coagulation markers along
with significant thrombotic complications. Post-mortem examinations show severe …

The exceptional outbreak of COVID-19 pandemic has let the scientific community to work
closely and quickly learnt things in a very short period of time. This has let us recognize that …

Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …

Background: The use of anticoagulants has been endorsed by different hematological
societies as coagulation abnormalities are key features of COVID-19 patients. This …

Background COVID-19 is a respiratory disease that results in a prothrombotic state
manifesting as thrombotic, microthrombotic and thromboembolic events. As a result, several …

Background: Emerging data suggest that coagulopathy, cytokine storm, and acute
respiratory distress syndrome are associated with the 2019 coronavirus disease (COVID …

Data on the prognosis of patients treated with oral anticoagulation (OAC) prior to hospital
admission for COVID-19 remains controversial and insufficient. Therefore, we endeavored to …